Status:
ACTIVE_NOT_RECRUITING
YOGA-CF (Yoga Outcomes Get Assessed in Cystic Fibrosis)
Lead Sponsor:
Royal Brompton & Harefield NHS Foundation Trust
Conditions:
Cystic Fibrosis
Eligibility:
All Genders
16+ years
Phase:
NA
Brief Summary
The goal of this clinical trial is to investigate the effects of yoga participation for adults with cystic fibrosis. The main question it aims to answer is: does participation in yoga affect health-r...
Eligibility Criteria
Inclusion
- Diagnosis of CF (confirmed by standard criteria; (Farrell et al. 2017))
- Sixteen years of age or over
- Home internet access
- Ability to complete questionnaires in English
- Stable CF disease as judged by the investigator, a senior CF clinician
Exclusion
- Inability to consent for treatment or measurement
- Current participation in another interventional study of a medicinal product
- Current haemoptysis (greater than streaking in the sputum)
- Known pregnancy at time of recruitment
- Forced expiratory volume in 1 second (FEV1) below 30% predicted at baseline
- Use of ambulatory oxygen therapy, long-term oxygen therapy (LTOT) or non-invasive ventilation
- Current regular participation in yoga practice
- Current neurological or musculoskeletal injury which would prevent completion of yoga
- Diagnosis of osteoporosis (bone density Z score \<-2.5) or history of spontaneous spinal fractures
- Uncontrolled gastroesophageal reflux
- Acute pulmonary exacerbation within 28 days of screening
Key Trial Info
Start Date :
April 22 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 31 2026
Estimated Enrollment :
314 Patients enrolled
Trial Details
Trial ID
NCT06120465
Start Date
April 22 2024
End Date
January 31 2026
Last Update
July 29 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Royal Brompton Hospital
London, Greater London, United Kingdom, SW3 6NP